tradingkey.logo

Catheter Precision Inc

VTAK
查看详细走势图
1.890USD
+0.050+2.81%
收盘 02/06, 16:00美东报价延迟15分钟
3.11M总市值
0.05市盈率 TTM

Catheter Precision Inc

1.890
+0.050+2.81%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.81%

5天

-2.58%

1月

-6.67%

6月

-44.33%

今年开始到现在

+3.28%

1年

-74.30%

查看详细走势图

TradingKey Catheter Precision Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Catheter Precision Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名147/205位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价38.00。中期看,股价处于下降通道。近一个月,市场表现一般,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Catheter Precision Inc评分

相关信息

行业排名
147 / 205
全市场排名
481 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Catheter Precision Inc亮点

亮点风险
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
业绩高增长
公司营业收入稳步增长,连续3年增长2900.00%
业绩增长期
公司处于发展阶段,最新年度总收入420.00K美元
估值高估
公司最新PE估值0.05,处于3年历史高位
机构减仓
最新机构持股17.75K股,环比减少65.16%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.33

分析师目标

根据 0 位分析师
--
评级
38.000
目标均价
+1753.66%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Catheter Precision Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Catheter Precision Inc简介

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
公司代码VTAK
公司Catheter Precision Inc
CEOJenkins (David A)
网址https://www.ramed.com/
KeyAI